Prasugrel

For instance, Eli Lilly and Co., which is developing a drug called Prasugrel to reduce the risk of blood clots, recently decided to spend as much as $400 million to run trials against Bristol-Meyers Squibb's similar drug, Plavix.

Reference Pricing For Drugs Chuck Farkas 2006

Seth is worried that, like ARB, Prasugrel, the latest clot buster in the market, might find easy access to patients and start competing with existing cheaper alternatives.

A Jagged Little Pill 2011

One alternative is another drug, Prasugrel; a third pill, Brillinta, is awaiting a decision on marketing approval at the FDA.

Four Heart Treatments Questioned In Studies Ron Winslow 2010

Prasugrel would compete against Plavix, the world's second-biggest selling drug by sales after Lipitor.

FDA Says It Erred on Doctor 2009

Prasugrel isn't on the market yet, and it's unclear when the FDA will decide whether to approve it.

FDA Says It Erred on Doctor 2009

Prasugrel: 643 patients (9.9%), had life-threatening events.

Experimental heart drug beats Plavix in trials 2007

Prasugrel cut in half the number of potentially deadly blood clots that formed in stents, springlike devices used to prop arteries open.

Experimental heart drug beats Plavix in trials 2007

The FDA said, in a list of questions the panel is being asked to vote on, the study showed that for 1,000 patients treated with Prasugrel compared with Plavix, Prasugrel would prevent an additional 20 heart attacks and two cardiovascular-related deaths but would likely result in two fatal bleeding events and four life-threatening bleeding events.

FDA Reviewers Recommend Agency Approve Prasugrel 2009

Prasugrel is more effective than Plavix in preventing heart attacks, according to an analysis by the agency's staff released Friday.

FDA Panel May Recommend High Fence Around Lilly Clot Drug 2009

Prasugrel is designed to keep blood platelets from sticking together to form dangerous blood clots that can cause heart attacks and strokes.

FDA Panel Recommends Approval of Lilly's Prasugrel 2009